Sensorion SA (EPA:ALSEN)
6.61
-0.53 (-7.38%)
Oct 2, 2026, 5:35 PM CET
Sensorion Employees
Sensorion had 66 employees as of June 30, 2026. The number of employees increased by 3 or 4.76% since the number was reported on December 31, 2025.
Employees
66
Change
3
Growth
4.76%
Revenue / Employee
€93,258
Profits / Employee
€517,061
Market Cap
68.12M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 66 | 3 | 4.76% |
| Dec 31, 2025 | 63 | 0 | - |
| Dec 31, 2024 | 63 | 6 | 10.53% |
| Dec 31, 2023 | 57 | 11 | 23.91% |
| Dec 31, 2022 | 46 | 8 | 21.05% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Innate Pharma | 164 |
| Transgene | 145 |
| Adocia | 73 |
| OSE Immunotherapeutics | 64 |
| Fermentalg | 64 |
| ABIONYX Pharma | 49 |
| Valerio Therapeutics Société anonyme | 25 |
Sensorion News
- 9 days ago - Sensorion Earnings release: H1 2026 - Filings
- 9 days ago - Sensorion Quarterly report: H1 2026 - Filings
- 10 days ago - Sensorion Transcript: Status update - Transcripts
- 10 days ago - Sensorion Slides: Status update - Filings
- 4 weeks ago - Sensorion Secures ANSM Approval To Launch Phase I/II HearConnex Trial Of SENS-601 In France - Nasdaq
- 4 weeks ago - Sensorion Slides: Corporate presentation - Filings
- 3 months ago - Sensorion Slides: Corporate presentation - Filings
- 3 months ago - Sensorion Advances SENS-601 For GJB2 Hearing Loss And Discontinues SENS-501 Trials; Stock Down - Nasdaq